Driving reinvestment in R&D for antibiotics and advocating their responsible use

Setting, Communicating and Revising Public Health Priorities

There are numerous stakeholder engagement opportunities for individuals and institutions, both public and private, which are involved in public health, health policy and administration, research, science and health communication, and the pharmaceutical industry.

Stakeholder input is required for:

– the results of the mathematical modelling, – COMPLETED

– the clinical impact of emerging MDR pathogens and antibiotic resistance, and – COMPLETED

– developing priorities of future need for new antibiotics – COMPLETED

– completing a survey on global incidence of four drug-resistant organisms. Access the survey hereSurvey still accessible

For more information on the team responsible for these activities, see Work Package 1B: Setting, communicating and revising public health priorities


Back to Antimicrobial Use and Stewardship

Back to Stakeholder Engagement